Screening for sickle cell and thalassaemia in primary care: a cost-effectiveness study

Keyphrases

• Primary Care 100%
• Cost-effectiveness Study 100%
• Sickle Cell Disease 100%
• Sickle Thalassemia 100%
• Sickle Cell Thalassemia 66%
• Confidence Interval 33%
• Reproductive Decision-making 33%
• Midwife Care 33%
• Disease Screening 33%
• Primary Care Screening 33%
• Thalassemia Screening 33%
• Ethnic Minorities 16%
• First Trimester 16%
• Cost-effectiveness 16%
• Midwives 16%
• Inherited Disorders 16%
• Hemoglobin 16%
• High Cost 16%
• Cost-effectiveness Analysis 16%
• Antenatal Screening 16%
• Primary Care Setting 16%
• Screening Approach 16%
• NHS Costs 16%
• Hemoglobinopathies 16%
• Inner-city Area 16%
• Sequential Screening 16%
• Pregnancy Confirmation 16%

Medicine and Dentistry

• Primary Health Care 100%
• Cost-Effectiveness Analysis 100%
• Effectiveness Study 100%
• Thalassemia 100%
• Sickle Cell 100%
• Sickle-Cell Disease 44%
• Sickle Cell Beta Thalassemia 44%
• Health Care Cost 33%
• Decision Making 11%
• First Trimester Pregnancy 11%
• Ethnic Minority Group 11%
• Antenatal Screening 11%
• Disease 11%
• Hemoglobinopathy 11%